Jeff Aronin is a one-of-a-kind businessman. He helps develop biotech and healthcare startups. Currently, he is the chairman and CEO of Paragon Biosciences, LLC. This company seeks to treat diseases that rob patients of their mobility and quality of life. With Aronin at the helm, Paragon is making a big impact.
Paragon makes it possible for biotech firms to get results. Aronin and his team bring scientists and businesspeople together. Jeff Aronin has a broad range of skills. His experience in marketing, finance and business development are keys to Paragon’s success.
Recently, Aronin won the 2017 Weizmann Leadership Award. This honor recognizes Aronin for his uniquely effective leadership style. Although he works in a highly regulated, high stress industry, Aronin always has time to mentor young entrepreneurs. He also sets a tone of superior ethics and values.
Aronin’s associates have all been wowed over the years by his committment to patient care. He’s never lost sight of the fact that diseases are human tragedies. Unlike some people in the biotech and pharmaceutical spaces, Jeff Aronin makes it a point to build business models around patient needs. Nothing makes him happier than seeing a useful treatment get approved. He’s happy to help companies shepherd their discoveries and treatments through the tangled FDA approval process.
Unlike some CEOs who sow resentment among their employees, Aronin inspires loyalty. Many members of his team have been with him for over 10 years. This is highly unusual in such a competitive and high-stress industry. Aronin is enthusiastic, happy to collaborate and loves his work. But there is more to him than that.
Jeff Aronin also makes it a point to give back. He supports non-profits including Juvenile Diabetes Research Foundation, Cystic Fibrosis Foundation and the JED Foundation for Depression. He’s also a devoted family man. His wife Lisa and his three daughters are the cornerstone of his life. He knows that without their support, he couldn’t have achieved the level of success he has.